Indazole derivatives as JNK inhibitors and compositions and methods related thereto
申请人:Bhagwat S. Shripad
公开号:US20050107457A1
公开(公告)日:2005-05-19
Compounds having activity as selective inhibitors of JNK are disclosed. The compounds of this invention are indazole derivatives having the following structure:
wherein R
1
, R
2
and A are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to JNK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.
Compounds of formula (I): wherein variable groups are as defined within; for use in the inhibition of 11βHSD1 are described.
描述了式(I)的化合物:其中变量基团如定义的那样;用于抑制11βHSD1。
787. Polymethin dyes from 4 : 5-disubstituted thiazoles
作者:Edward B. Knott
DOI:10.1039/jr9520004099
日期:——
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity
作者:Seth Daly、Kathryn Hayden、Indranil Malik、Nikki Porch、Hong Tang、Snezna Rogelj、Liliya V. Frolova、Katrina Lepthien、Alexander Kornienko、Igor V. Magedov
DOI:10.1016/j.bmcl.2011.06.081
日期:2011.8
A novel reaction of indole with aryldiazonium salts leading to the formation of 2-aryl-3-(arylazo)indoles was discovered. The products were found to possess potent anti-MRSA and anti-LLVRE activities. The SAR studies indicate that the potentially metabolically labile azo functionality can be replaced with ether oxygen and thioether sulfur atoms without any loss of activity. (C) 2011 Elsevier Ltd. All rights reserved.
Antiproliferative activity of 2,3-disubstituted indoles toward apoptosis-resistant cancers cells
作者:Igor V. Magedov、Florence Lefranc、Liliya V. Frolova、Laetitia Moreno Y. Banuls、Amanda S. Peretti、Snezna Rogelj、Véronique Mathieu、Robert Kiss、Alexander Kornienko
DOI:10.1016/j.bmcl.2013.03.110
日期:2013.6
Many types of cancer, including glioma, melanoma, NSCLC, among others, are resistant to apoptosis induction and poorly responsive to current therapies with propaptotic agents. We describe a series of 2,3-disubstituted indoles, which display cytostatic rather than cytotoxic effects in cancer cells, and serve as a new chemical scaffold to develop anticancer agents capable of combating apoptosis-resistant cancers associated with dismal prognoses. (C) 2013 Elsevier Ltd. All rights reserved.